Manufacturer record
Exemep Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Exemep Pharmaceuticals (Gujarat) was declared Not of Standard Quality in December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SER240002B FP, Sertraline Hydrochloride (USP/ EP) (exp Apr 2025). CDTL Mumbai (CDSCO lab) found it not of standard quality: "Related substances". Listed in the December 2024 alert.
Records by type
1 record linked to Exemep Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sertraline Hydrochloride (USP/ EP) | Batch SER240002B FPMfg May 2024 · Exp Apr 2025 | "Related substances"Related substances | CDTL MumbaiCDSCO lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.